General Medicine and Primary Care

Episodes 61-75 of 103

• 

  RestartResume

  Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments

  CME/CE

  Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments

  • 

    

    Scott Kahan, MD, MPH

    Peer

  • 

    

    Ken Fujioka, MD

    Peer

  • 

    

    Carol Wysham, MD

    Peer

  0.50 credits

• 

  RestartResume

  Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)

  CME/CE

  Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)

  • 

    

    Annie Levesque, MD, MSc

    Peer

  • 

    

    Ethan A. Cowan, MD

    Peer

  0.50 credits

• 

  RestartResume

  Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

  CME/CE

  Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

  • 

    

    Lee Shulman MD, FACOG, FACMG

    Peer

  • 

    

    Kristina Deligiannidis, MD

    Peer

  0.50 credits

• 

  RestartResume

  Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?

  CME/CE

  Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?

  • 

    

    Stefan D. Anker, MD, PhD

    Peer

  • 

    

    John Cleland, MD

    Peer

  • 

    

    Piotr Ponikowski, MD, PhD, FESC, FHFA

    Peer

  0.25 credits

• 

  MinuteCE®

  New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors

  • 

    

    Christopher B. Granger, MD

    Peer

  • 

    

    Manesh R. Patel, MD

    Peer

  • 

    

    M. Cecilia Bahit, MD

    Peer

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 credits 5 episodes

• 

  RestartResume

   The DOAC Revolution: What Have We Learned?

  MinuteCE®

   The DOAC Revolution: What Have We Learned?

  • 

    

    Christopher B. Granger, MD

    Peer

  1.50 program credits

• 

  RestartResume

  While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?

  MinuteCE®

  While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 program credits

• 

  RestartResume

  While DOACs are Good for Some Things, They Are Not for Everyone

  MinuteCE®

  While DOACs are Good for Some Things, They Are Not for Everyone

  • 

    

    M. Cecilia Bahit, MD

    Peer

  1.50 program credits

• 

  RestartResume

  The Path Forward: What’s On The Horizon?

  MinuteCE®

  The Path Forward: What’s On The Horizon?

  • 

    

    Manesh R. Patel, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Questions & Answers from the AHA 2023 Symposium

  MinuteCE®

  Questions & Answers from the AHA 2023 Symposium

  • 

    

    Manesh R. Patel, MD

    Peer

  • 

    

    M. Cecilia Bahit, MD

    Peer

  • 

    

    Elaine Hylek, MD, MPH

    Peer

  1.50 program credits

• 

  RestartResume

  Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation

  CME/CE

  Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation

  • 

    

    Cara Dolin, MD

    Peer

  • 

    

    Jennifer Simpson

    Peer

  • 

    

    Diana Girnita, MD ,PhD

    Peer

  1.00 credits

• 

  MinuteCE®

  The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications

  • 

    

    Richard Johnson, MD

    Peer

  • 

    

    Abdul Abdellatif, MD, FASN

    Peer

  • 

    

    John K. Botson, MD, RPh

    Peer

  • 

    

    Brittany Weber, MD, PhD

    Peer

• 

  RestartResume

  Gout Beyond the Joints: What’s the Hidden Danger?

  MinuteCE®

  Gout Beyond the Joints: What’s the Hidden Danger?

  • 

    

    Richard Johnson, MD

    Peer

• 

  RestartResume

  Is Gout Hiding in the Nephrology Clinic? 

  MinuteCE®

  Is Gout Hiding in the Nephrology Clinic? 

  • 

    

    Abdul Abdellatif, MD, FASN

    Peer

  • 

    

    Richard Johnson, MD

    Peer

• 

  RestartResume

  Is Managing Gout in the Nephrology Clinic a Challenge?

  MinuteCE®

  Is Managing Gout in the Nephrology Clinic a Challenge?

  • 

    

    Richard Johnson, MD

    Peer

  • 

    

    Abdul Abdellatif, MD, FASN

    Peer

• Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• Next